ABSTRACT
Background The management of Type 2 Diabetes Mellitus (T2DM) heavily relies on lifestyle choices and adherence. Opting for a high-risk lifestyle can exacerbate the impact on individuals with T2DM, worsening their condition. These approaches encompass self-care practices, cognitive behavioral strategies, training for family support, and educational initiatives focusing on lifestyle changes. Motivational interviewing is one strategy to changes behavior of T2DM patients.
Method This study reviewed the literature following the PRISMA guidelines (2019– 2023). The exploration involved keyword searches for “motivational interviewing,” “T2DM,” “lifestyle,” and “glycemic index” across databases such as Scopus, Science Direct, and ProQuest. Inclusion criteria encompassed quantitative research design, English language publications, research involving patients with T2DM, motivational interviewing, lifestyle modifications, and glycemic index. This resulted in the identification of 286 papers. A PICO synthesis and grouping method was used to analyze the data, aligned with the Cochrane Handbook for Systematic Reviews. The methodological quality assessment, carried out using the Joanna Briggs Institute Critical Appraisal methodology, indicated that adopting a multidisciplinary approach involving ontological, epistemological, and axiological inquiry is a robust foundation for enhancing health information systems and clinical practice.
Results This study reviewed ten articles focusing on using motivational interviewing techniques to improve T2DM patients so that they can change their lifestyle and manage their glycemic index in the long term. Motivational interviewing can be conducted face to face for an average of 10-12 sessions, approximately3-6 months, both online and through intensive intervention.
Conclusion This study can demonstrate how motivational interviews can improve the behavior of T2DM patients by changing lifestyle and reducing the glycemic index in T2DM patients.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript
